Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Donor Versus Autologous Fecal Microbiota Transplantation for Axial Spondyloarthritis: a Double Blind, Placebo-Controlled, Randomized Trial

NCT06451588 is registered in ClinicalTrials.gov with University Hospital of North Norway as lead sponsor.

NCT NCT06451588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06451588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Donor Versus Autologous Fecal Microbiota Transplantation for Axial Spondyloarthritis: a Double Blind, Placebo-Controlled, Randomized Trial
Lead sponsor
University Hospital of North Norway
Phase
Phase 2
Overall status
Recruiting
Start date
June 1, 2024
Completion date
November 30, 2027
Enrollment
99 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis, arthritis, axial spondyloarthritis, dysbiosis, joint diseases, musculoskeletal diseases, spinal disease, spondylitis, spondyloarthritis